YUANMING CAPITAL
YuanMing Capital is a healthcare specialty fund focusing on China-US cross border investments with offices in Beijing and New York City. The investment team has rich industry experience and a successful investment track record. The fund invests in therapeutics, medical devices, diagnostics as well as healthcare service companies based in US and/or China. We seek to bring capital and strategic resources to the future leaders of the industry.
YUANMING CAPITAL
Social Links:
Industry:
Finance Financial Services
Founded:
2015-08-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Apps For Business GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-01 | CF PharmTech | YuanMing Capital investment in Series F - CF PharmTech | 360 M CNY |
| 2020-02-18 | CANbridge Pharmaceuticals | YuanMing Capital investment in Series D - CANbridge Pharmaceuticals | 98 M USD |
| 2018-07-17 | Ascentage Pharma | YuanMing Capital investment in Series C - Ascentage Pharma | 150 M USD |
| 2018-06-26 | Adlai Nortye | YuanMing Capital investment in Series B - Adlai Nortye | 53 M USD |
| 2018-06-14 | Mevion Medical Systems | YuanMing Capital investment in Private Equity Round - Mevion Medical Systems | 150 M USD |
| 2018-05-14 | Ansun BioPharma | YuanMing Capital investment in Series A - Ansun BioPharma | 85 M USD |
| 2018-03-07 | JW Therapeutics | YuanMing Capital investment in Series A - JW Therapeutics | 90 M USD |
| 2017-05-23 | CANbridge Pharmaceuticals | YuanMing Capital investment in Series B - CANbridge Pharmaceuticals | 25 M USD |
| 2016-12-26 | Ascentage Pharma | YuanMing Capital investment in Series B - Ascentage Pharma | 500 M CNY |
| 2016-01-28 | aptX | YuanMing Capital investment in Series A - aptX | 20 M USD |